Nikhil Mehta
No más puestos en curso
Perfil
Nikhil Mehta worked as Vice President-Global Regulatory Affairs at Merck & Co., Inc. from 2010 to 2015.
He then worked as Chief Regulatory Strategist & Executive VP at Tang Capital Management LLC.
In 2015, he joined Baxalta, Inc. as Global Head-Regulatory Affairs, where he worked until 2016.
From 2017 to 2019, he worked as Senior VP-Regulatory & Quality Assurance at AVEO Pharmaceuticals, Inc. Dr. Mehta holds a doctorate degree from Rutgers State University of New Jersey.
Antiguos cargos conocidos de Nikhil Mehta.
| Empresas | Cargo | Fin |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | General Counsel | 08/10/2019 |
| BAXALTA INC | General Counsel | 01/06/2016 |
| MERCK & CO., INC. | General Counsel | 01/01/2015 |
Tang Capital Management LLC
 Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | General Counsel | - |
Formación de Nikhil Mehta.
| Rutgers State University of New Jersey | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | Finance |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Nikhil Mehta
